Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Pre-clinical Trillium Technologies was acquired for US$2.3 B

View:

Post by Noteable on Apr 24, 2023 10:34am

Pre-clinical Trillium Technologies was acquired for US$2.3 B

I don't have to read some non-expert analytical pulp to see what really is happening in the field of oncology to know what the REAL valuations are for late stage Phase 3 ready platform drug companies.

Unfortunately Canadafan and his supporters are just uninformed parrots of some obscure and gross information produced for the general public's consumption, which has nothing to do with the current state of oncology company valuations.

223

Comment

Comment by Noteable on May 28, 2023 7:08pm

Pre-clinical Trillium Therapeutics' acquisition by Pfizer a good example of what is currently happening in the biotech M&A space and what will continue to happen moving forward. https://www.barchart.com/stocks/quotes/TRIL

119

Comment

Comment by Noteable on Nov 23, 2023 10:14pm

As posted beforehand, Pfizer's US$2.3 Billion of the pre-clinical Trillium Therapeutics is another good example of the type of premiums Big Pharma are having to pay for upstream biological drug assets that still remain in the pre-clinical stage. ONCY on the otherhand is a late stage biological drug development company in a Phase 3 ready state in multiple cancer indications, including ...more

201

Comment

Oncolytics Biotech Inc